United Kingdom — The delicate balance between HIV treatment and recreational drug use requires careful consideration, as the interaction between these substances can significantly impact their effectiveness and induce unforeseen side effects. While extensive research exists for prescribed medications, understanding the implications of illicit drugs remains a challenge due to limited medical investigation in this area. Nonetheless, recognizing the potential interactions between anti-HIV drugs and recreational substances is crucial for individuals seeking to manage their health effectively.
DRUG INTERACTIONS & SHARED METABOLIC PATHWAYS
Certain anti-HIV drugs and recreational substances share metabolic pathways within the body, altering the effects of both when used simultaneously. Notably, boosting agents like ritonavir and cobicistat, commonly used in HIV treatment, can influence the metabolism of both prescribed and recreational drugs. The intricate nature of drug purity and composition in illicit substances further complicates predicting how they will interact with HIV medications.
RITONAVIR & COBICISTAT: KEY PLAYERS
Ritonavir (Norvir) and Cobicistat (Tybost), as boosting agents, play a pivotal role in enhancing the effectiveness of other antiretrovirals in HIV treatment, making the liver breakdown the primary drug slowly, allowing it to stay in the body longer or at higher levels. The primary drug is essentially ineffective without aid of the boosting agent. Norvir and Tybost are the most common protease inhibitors, others include Prezista, Reyataz, and Kaletra. Tybost is typically taken with Vitekta and is included in the compound pills Stribild, Genvoya, Rezolsta, Evotaz, and Symtuza.
The interaction with protease inhibitors and recreational drugs, including cocaine, GHB, crystal methamphetamine, MDMA, and others, can lead to serious side effects and greater risk of overdose. Similarly with HIV medications, the liver processes the recreational drug more slowly, allowing it to remain in the body for longer and at higher concentrations. This risk is particularly heightened during the initial four weeks of starting a new HIV treatment combination.
RITONAVIR & COBICISTAT: RECREATIONAL DRUGS OF CONCERN
Dangerous interactions have been documented between ritonavir or cobicistat and several recreational drugs, including:
- Cocaine (C, coke, rocks)
- GHB (G, Gina, gamma-hydroxybutyrate)
- Crystal methamphetamine (crystal, Tina, ice, meth)
- MDMA (ecstasy, X, Molly)
- Mephedrone (meow meow, bath salts, M-CAT)
- Ketamine (K special K, Kit Kat)
- Erectile dysfunction drugs (Viagra, Cialis, Levitra)
- Benzodiazepines (benzos, Valium, Xanax)
- Fentanyl (China White, Dance Fever, TNT)
Interactions may increase the intensity of the effect of the recreational drug to unpleasant and/or dangerous levels. Experts classify the potentials for interactions with the first five drugs lsited as “moderate” and the last four listed classified as “high”.
Several deaths have been documented in people taking Ritonavir alongside crystal meth, MDMA, or ketamine in particular. Ketamine interactions have also led to liver and bile duct damage. Erectile dysfunction (ED) medications pose an increased danger to the heart. Benzos result in unintended passing out. Poppers also interact with ED drugs causing dangerous and sudden drops in blood pressure, this occurrence is even more frequent when used in combination with HIV treatments. Recent studies have shown cannabis use and some anti-HIV drugs increase the effects of cannabis.
BROADER IMPACTS OF RECREATIONAL DRUG USE
Managing potential interactions during the initial stages of HIV treatment is crucial. Open communication with healthcare providers allows individuals to make informed decisions based on their unique situations. Beyond drug interactions, recreational drug use can have broader impacts on physical and mental health, sleep patterns, making missed doses of HIV medication more likely, and decision-making in sexual situations about what may be safe or appropriate.
SEEKING SUPPORT & INFORMATION
For those concerned about their drug use, reaching out to HIV clinics, local services, or specialized support services, like SAMHSA in the U.S., can provide valuable information and assistance. Recognizing the complex interplay between HIV treatment and recreational drug use allows individuals to make informed choices for their overall well-being.
